BioXcel Therapeutics, Inc. insider trading

BTAINASDAQ

$0.05+0.01 (+15.56%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (-98.0%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Unlock quarterly net flow

Key players

VMVimal MehtaCEO and President1.7578%of company
JRJavier RodriguezSee Remarks0.0857%of company
RIRichard I. SteinhartChief Financial Officer0.0841%of company
FYFrank YoccaChief Scientific Officer0.0837%of company
DJDavid J. MackDirector0.0649%of company
VOVincent O'NeillSee Remarks0.004%of company
MTMatthew T. WileyChief Commercial Officer0.0038%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
BTAI	Frank YoccaChief Scientific Officer	Open market sell$7.46K	-20.7%	$1.09	$7.46K	May 20, 2026	May 22, 2026
BTAI	Javier RodriguezSee Remarks	Open market sell$7.08K	-19.7%	$1.08	$7.08K	May 20, 2026	May 22, 2026
BTAI	Richard I. SteinhartChief Financial Officer	Open market sell$7.46K	-20.7%	$1.09	$7.46K	May 20, 2026	May 22, 2026
BTAI	Vimal MehtaCEO and President	Open market sell$21.2K	-3.4%	$1.09	$21.2K	May 20, 2026	May 22, 2026

End of history · 4 transactions